These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29165078)

  • 1. Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.
    Shahiwala A; Zarar A
    Curr Drug Deliv; 2018; 15(5):705-715. PubMed ID: 29165078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Araucaria Gum: Novel Natural Polymer for Controlled Drug Delivery. Development, In Vitro and In Vivo Evaluation of Araucaria Gum Based Matrix Tablets for Controlled Release.
    Naga Durga DH; Lohithasu D; Ramana Murthy Kolapalli V
    Curr Drug Deliv; 2017; 14(7):955-967. PubMed ID: 28034362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
    Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms.
    Lin Z; Zhou D; Hoag S; Qiu Y
    AAPS J; 2016 Mar; 18(2):333-45. PubMed ID: 26769249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.
    Mukherjee J; Das A; Chakrabarty US; Sahoo B; Sengupta P; Chatterjee B; Roy B; Pal TK
    Arzneimittelforschung; 2010; 60(8):506-9. PubMed ID: 20863007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of diclofenac sodium using hydrophilic matrices.
    Rao YM; Veni JK; Jayasagar G
    Drug Dev Ind Pharm; 2001 Sep; 27(8):759-66. PubMed ID: 11699827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium.
    Chuasuwan B; Binjesoh V; Polli JE; Zhang H; Amidon GL; Junginger HE; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2009 Apr; 98(4):1206-19. PubMed ID: 18752289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA
    Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of formulation on the dissolution profile of diclofenac sodium tablets.
    De Castro WV; Pires MA; Oliveira MA; Vianna-Soares CD; Nunan EA; Pianetti GA; Moreira-Campos LM; De Castro WV; Mertens-Talcott SU; Derendorf H
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1103-9. PubMed ID: 17012123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of in-vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs.
    Hosny EA; al-Helw AR; al-Dardiri MA
    Pharm Acta Helv; 1997 Jun; 72(3):159-64. PubMed ID: 9204774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations.
    Basmenji S; Valizadeh H; Zakeri-Milani P
    Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and comparison of release profiles: Effect of the dissolution method.
    Cascone S
    Eur J Pharm Sci; 2017 Aug; 106():352-361. PubMed ID: 28627469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B; Ibric S; Betz G; Zorica D
    Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.
    Roberts M; Pulcini L; Mostafa S; Cuppok-Rosiaux Y; Marchaud D
    Pharm Dev Technol; 2015 Jun; 20(4):507-12. PubMed ID: 24354893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.